The Scientist

» biotechnology

Most Recent

image: Robo-Eye to Enter US Market

Robo-Eye to Enter US Market

By | February 11, 2013

A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.

2 Comments

image: Pfizer Scientist Dies

Pfizer Scientist Dies

By | January 25, 2013

Genetics researcher and senior vice president of the pharmaceutical giant, David Cox, has passed away unexpectedly at age 66.

0 Comments

image: Single Patent for EU

Single Patent for EU

By | December 12, 2012

After decades of political wrangling, the European Union is poised to introduce a single patent system to reduce red tape and application costs for researchers and companies.

1 Comment

image: Chimp Patents Challenged

Chimp Patents Challenged

By | November 16, 2012

Three patents on transgenic apes in the European Union will be challenged by animal rights activists.

1 Comment

image: DNA for the Masses

DNA for the Masses

By | October 31, 2012

An Israeli company plans to synthesize DNA on demand for anyone, including those outside of research labs.  

1 Comment

image: Next Generation: In Vivo Drug Factories

Next Generation: In Vivo Drug Factories

By | August 13, 2012

Researchers use UV light to stimulate protein production in nano-sized delivery capsules in mice.

7 Comments

image: Next Generation: Regulated Wrinkles

Next Generation: Regulated Wrinkles

By | August 9, 2012

Researchers devise a way to create predictably patterned microwrinkles.

2 Comments

image: Medical Mavericks

Medical Mavericks

By | July 1, 2012

ALS patients take their fate into their own hands, self-administering an unapproved chemical and collating their results online.

11 Comments

image: 3-D Printing

3-D Printing

By | July 1, 2012

Is printing out your own lab equipment, molecular models, and drug compounds the wave of the future?

2 Comments

image: New FDA Review Process Debated

New FDA Review Process Debated

By | June 20, 2012

Industry experts discuss the agency’s plans to make the drug approval process more transparent.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech